ClassID:

92133

C07C69/017 - CPC Classification

Classification description:

Esters of carboxylic acids; Esters of carbonic or haloformic acids Esters of hydroxy compounds having the esterified hydroxy group bound to a carbon atom of a six-membered aromatic ring

Recent Application in this class:
#1
20250320174
2025-10-16

SPIN ON METAL-ORGANIC FORMULATIONS

#2
20250170265
2025-05-29

DIAZONIUM COMPOUNDS AND METHODS OF USE FOR DNA CLEAVAGE

#3
20230337677
2023-10-26

ARYL AND PYRIDYL AMIDE PESTICIDES AND COMPOSITIONS THEREOF

#4
20220348530
2022-11-03

Menaquinol compositions and methods of treatment

#5
20220340539
2022-10-27

COMPOUND AND PREPARATION METHOD THEREFOR AND USE THEREOF

#6
20220213021
2022-07-07

Compositions of biologically active menaquinol derivatives and methods of treatment

#7
20210395175
2021-12-23

HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

#8
20210171429
2021-06-10

Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders

#9
20210139781
2021-05-13

Polymerisable compounds and the use thereof in liquid-crystal displays

#10
20210062059
2021-03-04

COOLANT COMPOSITION AND COOLING SYSTEM

#11
20210030708
2021-02-04

Biologically active cannabidiol analogs

#12
20210009494
2021-01-14

Menaquinol compositions and methods of treatment

#13
20200399201
2020-12-24

Method for cycloaddition of dimethyl muconate

#14
20200399199
2020-12-24

Emodin succinyl ester compound, preparation method therefor and application thereof

#15
20200383944
2020-12-10

Biologically active cannabidiol analogs

#16
20200306217
2020-10-01

Biologically active cannabidiol analogs

#17
20200297688
2020-09-24

Biologically active cannabidiol analogs

#18
20200297687
2020-09-24

Biologically active cannabidiol analogs

#19
20200262972
2020-08-20

Bioderived biphenyl-containing compounds and their conversion to polymers and macromonomers

#20
20200248078
2020-08-06

Polymerizable compounds and the use thereof in liquid-crystal displays

#21
20200189999
2020-06-18

CYCLOALKYL-HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

#22
20200181061
2020-06-11

Compound, curable composition, cured product, optical member, and lens

#23
20200148622
2020-05-14

Mixture of polymerizable compound and method of producing the same

#24
20200087429
2020-03-19

METHODS OF MAKING STABLE AND THERMALLY POLYMERIZABLE VINYL, AMINO OR OLIGOMERIC PHENOXY BENZOCYCLOBUTENE MONOMERS WITH IMPROVIED CURING KINETICS

#25
20200087236
2020-03-19

Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders

#26
20200079718
2020-03-12

Menaquinol compositions and methods of treatment

#27
20190345092
2019-11-14

PREPARATION OF PHENOLIC (METH)ACRYLATES

#28
20190282514
2019-09-19

Medicinal use of serrulatane diterpenes

#29
20190263742
2019-08-29

Hydroxyl compounds and compositions for cholesterol management and related uses

#30
20190256777
2019-08-22

Polymerizable compounds and the use thereof in liquid-crystal displays

#31
20190192474
2019-06-27

Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer

#32
20190192473
2019-06-27

Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Rosacea

#33
20190177462
2019-06-13

Functionalized dimethoxyphenol monomers and methods for preparing such monomers

#34
20190169327
2019-06-06

Methods of making stable and thermally polymerizable vinyl, amino or oligomeric phenoxy benzocyclobutene monomers with improved curing kinetics

#35
20190084908
2019-03-21

CYCLOALKYL-HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

#36
20190031601
2019-01-31

Biologically active cannabidiol analogs

#37
20180370886
2018-12-27

Resorcinol derivatives for cosmetic use thereof

#38
20180290960
2018-10-11

Compositions of polyhydroxylated benzophenones and methods of treatment of neurodegenerative disorders

#39
20180282257
2018-10-04

Aromatic Monoester Compositions and Processes for Preparing Same

#40
20180273554
2018-09-27

Lipophenol compounds and uses thereof

#41
20180210341
2018-07-26

(Meth)acryloyl compound and method for producing same

#42
20180170846
2018-06-21

Resorcinol derivatives

#43
20180105505
2018-04-19

Glutathione-cleavable prodrug and methods of use thereof

#44
20180099921
2018-04-12

Mixture of polymerizable compound and method of producing the same

#45
20180028484
2018-02-01

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of glioma

#46
20170369418
2017-12-28

Polymerizable polar compound, liquid crystal composition, and liquid crystal display element

#47
20170349516
2017-12-07

Hydroxyl compounds and compositions for cholesterol management and related uses

#48
20170327741
2017-11-16

Bimesogenic compounds and mesogenic media

#49
20170320904
2017-11-09

Precipitation promoter and precipitation method in which same is used

#50
20170174957
2017-06-22

Polyphenylene ether oligomer and high-frequency copper clad laminate

#51
20170158604
2017-06-08

Production intermediate of polymerizable compound, production method for same, composition, and stabilization method

#52
20170121606
2017-05-04

Polymerizable compounds and the use thereof in liquid-crystal displays

#53
20170079994
2017-03-23

Prodrugs of vitamin K

#54
20170073286
2017-03-16

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#55
20170065547
2017-03-09

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer

#56
20170045816
2017-02-16

Aromatic glycol ethers as writing monomers in holographic photopolymer formulations

#57
20170037067
2017-02-09

Lipophenol compounds and uses thereof

#58
20160376211
2016-12-29

Cannabidinoid derivatives

#59
20160362606
2016-12-15

Polymerizable compounds and the use thereof in liquid-crystal displays

#60
20160303016
2016-10-20

Valeric acid esters of resveratrol and cosmetic compositions

#61
20160297743
2016-10-13

Acetyl salicyclic acid dimers, synthesis thereof, and uses thereof to prevent and treat complement-mediated disorders

#62
20160229791
2016-08-11

Malic acid esters of resveratrol and cosmetic compositions

#63
20160169920
2016-06-16

Ion sensor

#64
20160152895
2016-06-02

Polymerizable compound, polymerizable composition and liquid crystal display device

#65
20160145288
2016-05-26

Edible plasticizers for food and food packaging films

#66
20160060205
2016-03-03

Method of preparing fused ring indeno compounds

#67
20150376157
2015-12-31

Resist composition, method for forming resist pattern, polyphenol derivative for use in the composition

#68
20150353471
2015-12-10

Xanthine oxidase inhibitors and methods of use

#69
20150344784
2015-12-03

Compound having four polymerizable groups, liquid crystal composition and liquid crystal display device

#70
20150344389
2015-12-03

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#71
20150344388
2015-12-03

Hydroxyl compounds and compositions for cholesterol management and related uses

#72
20150141662
2015-05-21

Method of preparing fused ring indeno compounds

#73
20150141476
2015-05-21

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea

#74
20150102259
2015-04-16

Polymerizable compound, polymerizable composition and liquid crystal display device

#75
20150031651
2015-01-29

Prodrugs of vitamine K

#76
20140328823
2014-11-06

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer

#77
20140221680
2014-08-07

4-acylaralkylphenols and derivatives thereof

#78
20140206654
2014-07-24

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ

#79
20140179845
2014-06-26

Substituted naphthalenes as feedstock for plasticizer production

#80
20140135393
2014-05-15

Substituted cathechols as inhibitors of IL-4 and IL-5 for the treatment of bronchial asthma

#81
20140038980
2014-02-06

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease

#82
20130331589
2013-12-12

Chemical composition

#83
20130317245
2013-11-28

Intermediates for the synthesis of benzindene prostaglandins and preparations thereof

#84
20130281453
2013-10-24

Anti-cancer serine hydrolase inhibitory carbamates

#85
20130245128
2013-09-19

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's

#86
20130217685
2013-08-22

Compounds for modulating RNA binding proteins and uses therefor

#87
20130209483
2013-08-15

Resorcinol derivatives

#88
20130066070
2013-03-14

Process for producing ester compound

#89
20130053581
2013-02-28

Intermediates for the synthesis of benzindene prostaglandins and preparations thereof

#90
20130040916
2013-02-14

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#91
20120288461
2012-11-15

Ascorbic acid esters of resveratrol and cosmetic compositions

#92
20120288460
2012-11-15

Salicylic acid esters of resveratrol and cosmetic compositions

#93
20120225908
2012-09-06

Hydroxyl compounds and compositions for cholesterol management and related uses

#94
20120225890
2012-09-06

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease

#95
20120172617
2012-07-05

RESVERATROL INTERMEDIATES DAL

#96
20120172337
2012-07-05

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#97
20120136047
2012-05-31

Neuroprotective compositions and methods

#98
20120108853
2012-05-03

Method for producing trisphenols and monoester-substituted products thereof, and 4-acylaralkylphenol derivatives

#99
20120108549
2012-05-03

Neuroprotective compounds and their use

#100
20120087904
2012-04-12

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer

#101
20120035141
2012-02-09

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

#102
20120022284
2012-01-26

Preparation method of acylbenzenes

#103
20110311528
2011-12-22

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of psoriasis

#104
20110245341
2011-10-06

Process for the preparation of non-genotoxic diacetylrhein (diacerein) and formulations comprising non-genotoxic diacetylrhein

#105
20110237555
2011-09-29

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea

#106
20110201840
2011-08-18

Terminal 1,1-disubstituted alkenes, method of making and using thereof

#107
20110172239
2011-07-14

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease

#108
20110144358
2011-06-16

Process for the manufacture of trimethylhydroquinone dialkanoates

#109
20110136901
2011-06-09

Derivatives of 4-nerolidylcatechol, pharmaceutical compositions comprising them and process for producing the same

#110
20110065704
2011-03-17

Compounds for modulating RNA binding proteins and uses therefor

#111
20110046237
2011-02-24

Compounds with activity at estrogen receptors

#112
20110003860
2011-01-06

HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

#113
20100324314
2010-12-23

Process for producing ester compound

#114
20100249276
2010-09-30

Curatives for epoxy compositions

#115
20100217046
2010-08-26

Process for producing 3,4′ diacetoxybenzophenone

#116
20100185006
2010-07-22

Sirtuin activating compounds and processes for making the same

#117
20100179223
2010-07-15

Compounds, compositions, and methods for the treatment of synucleinopathies

#118
20100158843
2010-06-24

3-phenylpropanoic compound activators of receptors of PPAR type and pharmaceutical/cosmetic compositions comprised thereof

#119
20100130605
2010-05-27

Use of derivatives of sinapinic acid and compositions comprising such derivatives

#120
20100129471
2010-05-27

Iso CA-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerization

#121
20100113643
2010-05-06

CURATIVES FOR EPOXY ADHESIVE COMPOSITIONS

#122
20100010232
2010-01-14

Aryl derivatives of curcumin, demethoxycurcumin, bisdemethoxycurcumin or curcuminisoxazolide and their use as animal feed additives

#123
20090299102
2009-12-03

Apparatus and method for carrying out multiple reactions

#124
20090247489
2009-10-01

Dihydroxyl compounds and compositions for cholesterol management and related uses

#125
20090240078
2009-09-24

Multifunctional alcohols obtained from cardanol, multifunctional acrylic crosslinker and pendant phosphorous flame retardant derivatives thereof

#126
20090239955
2009-09-24

Obovatol derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and pharmaceutical composition for the prevention and treatment of cancer containing the same as an active ingredient

#127
20090197965
2009-08-06

COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE

#128
20090186138
2009-07-23

Method of Flavoring

#129
20090176773
2009-07-09

Non-Peptidic Inhibitors of AKAP/PKA Interaction

#130
20090149548
2009-06-11

1,2-diphenylethene derivatives for treatment of immune diseases

#131
20090143374
2009-06-04

Use of compounds and compositions for the treatment of amyloid diseases

#132
20090131706
2009-05-21

Process for the preparation of a diaryl carbonate

#133
20090118377
2009-05-07

APOGOSSYPOLONE AND THE USES THEREOF

#134
20090076114
2009-03-19

Cis-1,2-substituted stilbene derivatives and their use in preparation of drugs for treatment and/or prevention of diabetes

#135
20090069432
2009-03-12

Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease

#136
20090054681
2009-02-26

Process for producing cyclopropylphenol derivative

#137
20090036523
2009-02-05

Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same

#138
20090035242
2009-02-05

Emulsion cosmetic compositions containing resveratrol derivatives and linear or branched silicone

#139
20080255382
2008-10-16

Sirtuin activating compounds and methods for making the same

#140
20080249166
2008-10-09

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

#141
20080227942
2008-09-18

Hydroxyphenyl acrylate monomers and polymers

#142
20080167493
2008-07-10

METHODS FOR CONVERSION OF TYROSINE TO P-HYDROXYSTYRENE AND P-HYDROXYCINNAMIC ACID

#143
20080131382
2008-06-05

Resorcinol derivatives for skin

#144
20080125486
2008-05-29

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ

#145
20080114060
2008-05-15

Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer

#146
20080113948
2008-05-15

Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Psoriasis

#147
20080113947
2008-05-15

Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Rosacea

#148
20080064661
2008-03-13

Dihydroxyl compounds and compositions for cholesterol management and related uses

#149
20070276034
2007-11-29

Compounds, compositions and methods for the treatment of synucleinopathies

#150
20070225362
2007-09-27

Compounds, compositions and methods for the treatment of amyloid diseases such as systemic AA amyloidosis

#151
20070213569
2007-09-13

Processes for conversion of tyrosine to p-hydroxystyrene and p-acetoxystyrene

#152
20070197819
2007-08-23

Process for the preparation of stilbene derivatives

#153
20070179120
2007-08-02

Hydroxyl compounds and compositions for cholesterol management and related uses

#154
20070128242
2007-06-07

Polymeric compositions for controlled release or delivery of pharmacologically active agents

#155
20070123720
2007-05-31

Process for the preparation of 2,3,5-trimethylhydroquinone diacylates

#156
20070112206
2007-05-17

Manufacture of tocopheryl acetate

#157
20070111971
2007-05-17

Triphenylethylene compounds as selective estrogen receptor modulators

#158
20070092551
2007-04-26

Therapeutic agent

#159
20070054966
2007-03-08

Method for preparing novel transcription factors and use

#160
20070049762
2007-03-01

Process for the manufacture of trimethylydroquine dialkanoates

#161
20070032667
2007-02-08

Route to α- tocopheryl alkanoates and percursors thereof

#162
20060241154
2006-10-26

Benzotropolone derivatives and modulation of inflammatory response

#163
20060235234
2006-10-19

New route to alpha-tocopherol, alpha-tocopheryl alkanoates and precursors thereof

#164
20060229281
2006-10-12

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#165
20060210498
2006-09-21

Novel resorcinol derivatives for skin

#166
20060178435
2006-08-10

Apogossypolone and the uses thereof

#167
20060144723
2006-07-06

Device for securing valuables

#168
20060128997
2006-06-15

Method for the preparation of 1,5-bis(4-hydroxy-3-metoxy-phenyl)-penta-1,4-dien-3-one and derivatives with antitumoral properties

#169
20060122278
2006-06-08

Compounds with activity at estrogen receptors

#170
20060094886
2006-05-04

Manufacture of tocopheryl acetate

#171
20050228191
2005-10-13

Method for preparing hydroxystyrenes and acetylated derivatives thereof

#172
20050176824
2005-08-11

Substance having antitumor/anti-inflammatory activity

#173
20050113604
2005-05-26

Aldehyde conversion method using a molecular sieve and the use of the molecular sieve as a catalyst in said method

#174
20050101541
2005-05-12

Lignan derivatives

#175
20050065363
2005-03-24

Process for producing phenyl ester, and catalyst

#176
20050059841
2005-03-17

Processes for the preparation of a carboxylic anhydride and use of the carboxylic anhydride as an acylation agent

#177
20050054632
2005-03-10

Naphthyl compounds, intermediates, compositions, and methods of use

#178
20050049284
2005-03-03

Benzotropolone derivatives and modulation of inflammatory response

#179
20050043278
2005-02-24

Hydroxyl compounds and compositions for cholesterol management and related uses

#180
20050038286
2005-02-17

Manufacture of trimethylhydroquinone diacylates

#181
20050038268
2005-02-17

Method for the preparation of enterolactone from matairesinol

#182
20050009924
2005-01-13

Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives